DNA-polycation nanospheres as non-viral gene delivery vehicles

Journal of Controlled Release

Volumn 53, Issue 1-3, 1998, Pages 183-193

  Leong, K W ^a   Mao, H Q ^a   Truong Le, V L ^b   Roy, K ^a   Walsh, S M ^a   August, J T ^b  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

DNA nanoparticles; Gene delivery; Gene transfer; Nanospheres; Non viral

Indexed keywords

CALCIUM PHOSPHATE; CHITOSAN; DRUG CARRIER; GELATIN; LIPOFECTAMINE; LIPOSOME; NANOPARTICLE; POLYCATION; UNCLASSIFIED DRUG;

COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA TRANSFECTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG STORAGE; ENDOCYTOSIS; ENZYME DEGRADATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL LINE; DNA; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICROSPHERES; PARTICLE SIZE; POLYAMINES; TRANSFECTION;

EID: 0032580495     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00252-6     Document Type: Conference Paper

References (26)

1. Friedmann T. Human gene therapy - an immature genie, but certainly out of the bottle. Nature Med. 2:1996;144.
2. Crystal R.G. The gene as the drug. Nature Med. 1:1995;15.
3. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. Science. 270:1995;404.
4. Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology. 219:1996;220.
5. Knowles M.R.et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelial of patients with cystic fibrosis. N. Engl. J. Med. 333:1995;823.
6. Alton E.W., Geddes D.M. Gene therapy for cystic fibrosis: a clinical perspective. Gene Ther. 2:1995;88.
7. Caplen N.J.et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1:1995;39.
8. Cotten M., Wagner E. Non-viral approaches to gene therapy. Curr. Opin. Biotechnol. 4:1993;705-710.
9. A. Singhal, L. Huang, Gene transfer in mammalian cells using liposomes as carriers, in: J.A. Wolff (Ed.), Gene Therapeutics: Methods and Applications of Direct Gene Transfer, Birkhauser, Boston, 1994.
10. Schonfield J.P., Caskey C.T. Non-viral approaches to gene therapy. Br. Med. J. 51:1995;56.
11. Law D.et al. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6:1995;553.
12. Truong V., Williams J.R., Hildreth J., Leong K.W. Targeted delivery of immunomicrospheres in vivo. Drug Delivery. 2:1995;166.
13. Golumbek P., Azhari R., Jaff E., Levitsky H., Lazenby A., Leong K., Pardoll D. Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. Cancer Res. 53:1993;5841.
14. Brown K., Shao W., Bathon J., Leong K. Controlled drug delivery to the joints by enzymatically degradable microspheres. MRS Symp. Ser. 331:1994;290.
15. P.I. Rose, Gelatin, in: J.I. Kroschwitz (Ed.), Concise Encyclopedia of Polymer Science and Engineering, Wiley, New York, 1990, p. 430.
16. C.J. Brine, P.A. Sanford, J.P. Zikakis (Eds.), Advances in Chitin and Chitosan, Elsevier Applied Science, London, 1992.
17. Flotte T.et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA. 90:1993;10613.
18. Flotte T.et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promotor. J. Biol. Chem. 268:1993;3781.
19. J. Wolff (Ed.), Gene Therapeutics: Methods and Applications of Direct Gene Transfer, Birkhauser, Boston, 1994.
20. Felgner P.L.et al. Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413.
21. Brown K.E., Huang C.H., Dalal R., Bathon J., Leong K.W. Cationic gelatin as a gene carrier. Mater. Res. Soc. Symp. Ser. 394:1995;61.
22. H.Q. Mao, K. Roy, S.M. Walsh, J.T. August, K.W. Leong, DNA-chitosan nanospheres for gene delivery, in: International Symposium on Controlled Release of Bioactive Materials 1996, Kyoto, Japan, Controlled Release Society.
23. H.Q. Mao, K. Roy, V.L. Truong-Le, J.T. August, K.W. Leong, DNA-chitosan nanospheres: derivatization and storage stability, in: International Symposium on Controlled Release of Bioactive Materials 1997, Stockholm, Sweden, Controlled Release Society, p. 671.
24. S.M. Walsh et al., Combination of drug and gene delivery by gelatin nanospheres for the treatment of cystic fibrosis, in: Proceedings of the International Conference on Controlled Release of Bioactive Agents 1997, Stockholm, Sweden, p. 75.
25. V.L. Truong-Le, H.Q. Mao, S. Walsh, K.W. Leong, J.T. August, Delivery of DNA vaccine using gelatin-DNA nanospheres, in: International Symposium on Controlled Release of Bioactive Materials 1997, Stockholm, Sweden, Controlled Release Society, p. 39.
26. K. Roy, H.Q. Mao, K.W. Leong, DNA-chitosan nanospheres: transfection efficiency and cellular uptake, in: International Symposium on Controlled Release of Bioactive Materials 1997, Stockholm, Sweden, Controlled Release Society, p. 673.